Literature DB >> 21482066

Cognitive control of movement in Down syndrome.

Emiliano Brunamonti1, Pierpaolo Pani, Odysseas Papazachariadis, Paolo Onorati, Giorgio Albertini, Stefano Ferraina.   

Abstract

Inhibition of inappropriate responses allows to shape the motor behavior accordingly to the context in which a subject acts and is an essential executive function. Inhibition has been poorly investigated in Down Syndrome (DS) patients. We tested, using a countermanding task, the inhibitory control in a group of DS patients and in a group of patients with developmental disorders of non-genetic etiology, matched for mental age. We found that the duration of the stopping process, the stop signal reaction time (SSRT), was not statistically different in the two groups of patients. At the same time, the normalized inhibitory function resulted shallower in DS patients indicating a poor inhibitory control. We interpreted the results on the basis of the known anatomical differences in the brain of adult DS patients and more specifically in a possible altered dialogue between the fronto-striatal and fronto-cerebellar networks during motor control.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21482066     DOI: 10.1016/j.ridd.2011.03.008

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  11 in total

1.  Atrophic degeneration of cerebellum impairs both the reactive and the proactive control of movement in the stop signal paradigm.

Authors:  Giusy Olivito; Emiliano Brunamonti; Silvia Clausi; Pierpaolo Pani; Francesca R Chiricozzi; Margherita Giamundo; Marco Molinari; Maria Leggio; Stefano Ferraina
Journal:  Exp Brain Res       Date:  2017-07-17       Impact factor: 1.972

Review 2.  Down syndrome: the brain in trisomic mode.

Authors:  Mara Dierssen
Journal:  Nat Rev Neurosci       Date:  2012-12       Impact factor: 34.870

3.  Response abilities of children with Down Syndrome and other intellectual developmental disorders.

Authors:  Pratiksha Tilak Rao; Vasudeva Guddattu; John Michael Solomon
Journal:  Exp Brain Res       Date:  2017-02-24       Impact factor: 1.972

4.  Both the COMT Val158Met single-nucleotide polymorphism and sex-dependent differences influence response inhibition.

Authors:  Valentina Mione; Sonia Canterini; Emiliano Brunamonti; Pierpaolo Pani; Federica Donno; Maria Teresa Fiorenza; Stefano Ferraina
Journal:  Front Behav Neurosci       Date:  2015-05-19       Impact factor: 3.558

5.  Alpha- and beta-band oscillations subserve different processes in reactive control of limb movements.

Authors:  Pierpaolo Pani; Fabio Di Bello; Emiliano Brunamonti; Valeria D'Andrea; Odysseas Papazachariadis; Stefano Ferraina
Journal:  Front Behav Neurosci       Date:  2014-11-05       Impact factor: 3.558

6.  Response Inhibition and Interference Suppression in Individuals With Down Syndrome Compared to Typically Developing Children.

Authors:  Laura Traverso; Martina Fontana; Maria Carmen Usai; Maria C Passolunghi
Journal:  Front Psychol       Date:  2018-05-04

7.  Altered Hippocampal-Prefrontal Neural Dynamics in Mouse Models of Down Syndrome.

Authors:  Pishan Chang; Daniel Bush; Stephanie Schorge; Mark Good; Tara Canonica; Nathanael Shing; Suzanna Noy; Frances K Wiseman; Neil Burgess; Victor L J Tybulewicz; Matthew C Walker; Elizabeth M C Fisher
Journal:  Cell Rep       Date:  2020-01-28       Impact factor: 9.423

Review 8.  Molecular and cellular alterations in Down syndrome: toward the identification of targets for therapeutics.

Authors:  Nicole Créau
Journal:  Neural Plast       Date:  2012-07-12       Impact factor: 3.599

Review 9.  Building an adaptive brain across development: targets for neurorehabilitation must begin in infancy.

Authors:  Jamie O Edgin; Caron A C Clark; Esha Massand; Annette Karmiloff-Smith
Journal:  Front Behav Neurosci       Date:  2015-09-11       Impact factor: 3.558

10.  Cerebellar damage impairs executive control and monitoring of movement generation.

Authors:  Emiliano Brunamonti; Francesca R Chiricozzi; Silvia Clausi; Giusy Olivito; Maria Assunta Giusti; Marco Molinari; Stefano Ferraina; Maria Leggio
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.